Hexarelin · Research brief
Buy Hexarelin Peptide: What Hexarelin Is & Its Research
Short answer
The most repeated claim about hexarelin is that it is simply a more potent version of GHRP-6. That framing misses the property that pulled the compound into cardiovascular research in the first place: it binds a second receptor that has nothing to do with growth hormone at all.
Key takeaways
- Hexarelin is a synthetic hexapeptide growth hormone secretagogue, CAS 140703-51-1, molecular weight near 887 g/mol, sequence His-D-2-methyl-Trp-Ala-Trp-D-Phe-Lys-NH2.
- It acts at the GHS-R1a ghrelin receptor and also binds the CD36 scavenger receptor, which is what distinguishes it from selective secretagogues like Ipamorelin.
- Published research on the GHRP class reports diminished growth hormone response under repeated or continuous exposure, consistent with receptor desensitisation.
- Anyone preparing to buy hexarelin peptide should require a lot-specific certificate of analysis showing both HPLC purity and mass-spectrometry identity confirmation.
- Hexarelin is not an approved drug, is supplied for laboratory research only, and is listed by the World Anti-Doping Agency as a prohibited growth hormone secretagogue.
- Lyophilised material is stored frozen and protected from light, with repeated freeze-thaw cycles avoided to prevent aggregation.
The most repeated claim about hexarelin is that it is simply a more potent version of GHRP-6. That framing misses the property that pulled the compound into cardiovascular research in the first place: it binds a second receptor that has nothing to do with growth hormone at all.
Our team supplies research-grade material to laboratories and independent investigators, and the questions we field from people preparing to buy hexarelin peptide are consistently the same three. What does it do at the receptor level, what does the published safety literature actually report, and how do you tell a real lot-specific certificate of analysis from a decorative PDF?
What is hexarelin, and what should researchers check before they buy hexarelin peptide?
Hexarelin, also called examorelin, is a synthetic hexapeptide growth hormone secretagogue with CAS number 140703-51-1 and a molecular weight near 887 g/mol. It acts at the ghrelin receptor GHS-R1a and also binds the scavenger receptor CD36. Researchers who buy hexarelin peptide should confirm lot-specific HPLC purity and mass-spectrometry identity before procurement.
The common over-simplification is that hexarelin is GHRP-6 with a methyl group bolted on, so it must behave identically. It does not. That single 2-methyl substitution on the D-tryptophan residue changes metabolic stability and receptor behaviour, and studies report a considerably weaker appetite-stimulating effect than ghrelin itself produces. This brief covers the reported mechanism, what the desensitisation and safety literature describes, and how to evaluate a supplier before you buy hexarelin peptide.
The hexapeptide behind the name
Hexarelin is a six-amino-acid synthetic peptide with the sequence His-D-2-methyl-Trp-Ala-Trp-D-Phe-Lys-NH2, developed in the early 1990s from the GHRP-6 template as part of a family of synthetic growth hormone-releasing peptides. The C-terminus is amidated rather than free, which is a common stabilising modification in peptide chemistry, and the molecular formula is C47H58N12O6.
Its primary target is GHS-R1a, the growth hormone secretagogue receptor type 1a. That is the same G-protein-coupled receptor the natural hormone ghrelin binds. Activation at the pituitary somatotrophs and at hypothalamic sites is what the literature associates with pulsatile growth hormone release in study models.
This matters because it is a different pathway from the one used by GHRH analogues. Sermorelin, Tesamorelin and CJC-1295 No DAC act at the GHRH receptor. Hexarelin acts at the ghrelin receptor. Published work describes the two classes as acting through complementary rather than identical signalling, which is precisely why comparative study designs exist at all.
The literature on the GHRP class also reports modest concurrent rises in ACTH, cortisol and prolactin in study conditions, and hexarelin is not exempt from that pattern. Any honest research summary mentions it. Most product descriptions do not.
In our experience fielding technical questions from labs that buy hexarelin peptide, this receptor distinction is the single most misunderstood point in the entire category.
The CD36 pathway most hexarelin summaries skip
Hexarelin binds CD36, a scavenger receptor expressed on macrophages, cardiomyocytes and endothelial cells that participates in long-chain fatty acid uptake and oxidised LDL recognition. This is not a footnote. It is the reason hexarelin appears in cardiovascular research literature and not only in endocrinology literature, and studies report cardiac effects in animal models that appear at least partly independent of growth hormone release.
Here is the practical consequence most summaries ignore. Ipamorelin is described in the literature as a selective GHS-R1a agonist without meaningful CD36 activity. Hexarelin is not selective in that way. The real difference between the two compounds in a study design is receptor breadth, not potency, and treating them as interchangeable because both are labelled secretagogues is the procurement mistake we see most often.
The second point worth knowing before you buy hexarelin peptide concerns attenuation. Research on the GHRP class reports that the growth hormone response can diminish under continuous or repeated exposure, consistent with receptor desensitisation and downregulation. Published investigations have therefore tended to use intermittent rather than continuous exposure schedules, and reported study parameters vary substantially between protocols.
That detail changes how a research question should be framed. A study measuring a single acute response and a study measuring response across weeks are measuring two different pharmacological realities, and comparing their outputs as if they were the same endpoint produces conclusions the data does not support.
Where to Buy Hexarelin Peptide Without Guessing at Purity
The only defensible way to buy hexarelin peptide is from a supplier that publishes a lot-specific certificate of analysis showing HPLC purity alongside mass-spectrometry identity confirmation that matches CAS 140703-51-1 and a molecular weight near 887 g/mol. A generic COA with no lot number attached to it tells you nothing about the vial in your hand.
Three checks separate a serious supplier from a reseller. First, does the COA reference the specific lot printed on the vial label? Second, is the analytical work third-party, or performed and reported by the seller alone? Third, does the identity section confirm the sequence and observed mass, not just a purity percentage in isolation? Purity without identity is a number describing an unknown compound.
Handling matters as much as sourcing. Lyophilised peptides are supplied as a dry cake and are stored frozen, typically at minus 20 degrees Celsius, protected from light, with repeated freeze-thaw cycles avoided because each cycle risks aggregation and degradation of the peptide structure.
On regulatory status, be unambiguous. Hexarelin is not an FDA-approved drug for any indication, it is supplied for laboratory research use only, and it appears on the World Anti-Doping Agency prohibited list under the growth hormone secretagogue category. Real Peptides does not publish dosing, reconstitution or administration guidance for any catalog compound, because these are research materials and those decisions sit with a qualified investigator, not a supplier.
How hexarelin compares with other secretagogues in the literature
Researchers who buy hexarelin peptide are usually choosing between several secretagogue classes, and the distinctions are mechanistic rather than cosmetic. This table summarises what the published literature reports for each compound.
| Compound | Primary receptor target | What the literature reports | Reported secondary activity | Professional Assessment |
|---|---|---|---|---|
| Hexarelin (examorelin) | GHS-R1a, the ghrelin receptor | Potent growth hormone release in study models, with response attenuation described under repeated exposure | Binds CD36, giving it a cardiovascular research profile no other GHRP shares | The broadest research profile of the group, and the least selective; appropriate when CD36 involvement is part of the research question |
| GHRP-6 | GHS-R1a | The parent template hexarelin was derived from, with a strong reported orexigenic effect | Notable appetite stimulation reported, plus prolactin and cortisol movement | Useful as a comparator compound, but the appetite confound makes clean endpoint isolation harder |
| Ipamorelin | GHS-R1a, described as selective | Growth hormone release with a cleaner reported hormonal profile | Minimal reported effect on cortisol, prolactin or CD36 | The selectivity control in most comparative designs; choose it when isolating GHS-R1a signalling alone |
| CJC-1295 No DAC | GHRH receptor | Acts on a separate pathway from all GHRP-class compounds | No ghrelin-receptor or CD36 activity reported | Not a hexarelin substitute; the literature describes GHRH and GHS pathways as complementary, not interchangeable |
What If: Hexarelin Sourcing and Handling Scenarios
What if the certificate of analysis has no lot number on it?
Treat it as unverified material and request the lot-specific document before accepting the shipment. A COA without a lot reference cannot be tied to the vial you received, which means the analytical data describes a different batch or possibly no batch at all. Legitimate suppliers generate analytical documentation per synthesis run, so producing it should take minutes, not days.
What if the CAS number on the label does not match 140703-51-1?
Stop and confirm identity before the material enters any workflow. CAS 140703-51-1 is the registry identifier for hexarelin, and a mismatch means you are either looking at a different compound, a salt form described under a separate identifier, or a labelling error. Cross-reference the stated molecular weight and formula against the mass-spectrometry section of the COA, since those two data points together are far harder to fake than a printed number.
What if the lyophilised cake looks like loose flakes rather than a solid disc?
Document the appearance photographically and contact the supplier before use. Lyophilised peptide presentation varies legitimately with fill volume, vial geometry and the freeze-drying cycle, so flaky or partially collapsed cake is not automatically a defect. Genuine warning signs are discoloration, visible moisture, or a cake that has liquefied, all of which suggest a cold-chain excursion during transit.
What if a supplier says the COA is proprietary?
Buy elsewhere. Analytical documentation for a research compound is not intellectual property, and a supplier unwilling to publish purity and identity data for the lot you are purchasing is asking you to accept an unidentified white powder on faith. Our team publishes certificates openly for exactly this reason, because reproducibility in a laboratory starts with knowing what is in the vial.
The unglamorous truth about hexarelin reviews and safety claims
Here is the honest answer: most hexarelin reviews online are not reviews of hexarelin. They are reviews of shipping speed, packaging and customer service, written by people with no analytical means of confirming what the vial contained. A review cannot substitute for chromatography.
And the question of whether hexarelin is safe has no clean answer, because it is not an approved drug and its safety has never been established through a regulatory approval process. The literature describes effects observed under study conditions, including hormonal changes across the GHRP class. That is evidence about a research compound, not a safety clearance, and anyone presenting it as one is misreading it.
Our hexarelin listing and its supporting documentation sit alongside the rest of the catalog: the hexarelin product page, the published certificates of analysis for current lots, and the full research peptide catalog, where investigators comparing secretagogue classes frequently review Ipamorelin and CJC-1295 No DAC against hexarelin. Fulfilment and facility details are on our shipping information page.
Researchers who buy hexarelin peptide on the strength of a forum recommendation are outsourcing the most important variable in their study to a stranger. The compound itself is well characterised in the published literature, with a defined sequence, a registry number and a documented dual-receptor profile. What is not well characterised is the contents of an undocumented vial. Chromatography settles that question in an afternoon, and no amount of enthusiasm in a product review ever will.
References
Peer-reviewed sources on Hexarelin indexed in PubMed, listed for research context. Real Peptides supplies Hexarelin for laboratory research use only.
- Hexarelin alleviates apoptosis on ischemic acute kidney injury via MDM2/p53 pathway. European journal of medical research, 2023. PMID 37710348. doi:10.1186/s40001-023-01318-w
- Hexarelin attenuates abdominal aortic aneurysm formation by inhibiting SMC phenotype switch and inflammasome activation. Microvascular research, 2022. PMID 34856183. doi:10.1016/j.mvr.2021.104280
- Hexarelin modulates lung mechanics, inflammation, and fibrosis in acute lung injury. Drug target insights, 2021. PMID 34871336. doi:10.33393/dti.2021.2347
- Hexarelin Modulation of MAPK and PI3K/Akt Pathways in Neuro-2A Cells Inhibits Hydrogen Peroxide-Induced Apoptotic Toxicity. Pharmaceuticals (Basel, Switzerland), 2021. PMID 34066741. doi:10.3390/ph14050444
- Using Synchrotron Radiation Imaging Techniques to Elucidate the Actions of Hexarelin in the Heart of Small Animal Models. Frontiers in physiology, 2021. PMID 35126171. doi:10.3389/fphys.2021.766818
- Ghrelin receptor agonist hexarelin attenuates antinociceptive tolerance to morphine in rats. Canadian journal of physiology and pharmacology, 2021. PMID 32893668. doi:10.1139/cjpp-2020-0218
- Hexarelin targets neuroinflammatory pathways to preserve cardiac morphology and function in a mouse model of myocardial ischemia-reperfusion. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2020. PMID 32403043. doi:10.1016/j.biopha.2020.110165
- Hexarelin attenuates atherosclerosis via inhibiting LOX-1-NF-κB signaling pathway-mediated macrophage ox-LDL uptake in ApoE(-/-) mice. Peptides, 2019. PMID 31386895. doi:10.1016/j.peptides.2019.170122
Build a pack
Researching more than one compound?
Build a multi-vial pack and the discount applies automatically as you add doses.
Questions
RESEARCH USE ONLY · NOT EVALUATED BY THE FDA